Added to YB: 2021-06-08
Pitch date: 2021-06-08
HRTX [bullish]
Heron Therapeutics, Inc.
-97.33%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
Market Cap
$78.9M
Pitch Price
$14.13
Price Target
N/A
Dividend
N/A
EV/EBITDA
-22.28
P/E
-2.26
EV/Sales
1.23
Sector
Biotechnology
Category
N/A
Show full summary:
HERON THERAPEUTICS INC HRTX
A summary for this pitch has not been created yet.
Read full article (0 min)